• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Becton Dickinson (NY: BDX )

    232.21 +1.20 (+0.52%)
    Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,510,567
    Open 230.74
    Bid (Size) 230.00 (3)
    Ask (Size) 237.01 (1)
    Prev. Close 231.01
    Today's Range 229.40 - 232.64
    52wk Range 229.40 - 287.32
    Shares Outstanding 287,190,180
    Dividend Yield 1.57%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows
    Want quality picks and reliable income at a discount? Check out these Dividend Aristocrats trading at 52-week lows. 
    Via InvestorPlace
    AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
    AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. 
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property

    Performance

    YTD
    -5.38%
    -5.38%
    1 Month
    -2.32%
    -2.32%
    3 Month
    -0.89%
    -0.89%
    6 Month
    -10.48%
    -10.48%
    1 Year
    -8.43%
    -8.43%

    More News

    Read More
    Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?
    Via InvestorPlace
    Peering Into Becton Dickinson's Recent Short Interest
    Via Benzinga
    Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money'
    Via Benzinga
    Peering Into Becton Dickinson's Recent Short Interest
    Via Benzinga
    Becton Dickinson Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
    Via Benzinga
    Earnings Preview For Becton, Dickinson
    Via Benzinga
    Becton, Dickinson And Co. Dividend Stock Analysis
    Via Talk Markets
    FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns
    Via Benzinga
    Exposures Product Safety
    10 Big-Name Stocks Near 52-Week Lows: Are They A Buy?
    Via Talk Markets
    7 Robotic Surgery Stocks to Buy for the Future of Healthcare
    Via InvestorPlace
    3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
    Via The Motley Fool
    Here's How Much You Would Have Made Owning Becton Dickinson Stock In The Last 20 Years
    Via Benzinga
    Peeling Back The Layers: Exploring Becton Dickinson Through Analyst Insights
    Via Benzinga
    $1000 Invested In Becton Dickinson 20 Years Ago Would Be Worth This Much Today
    Via Benzinga
    3 Stocks to Buy at 52-Week Lows: March 4 Edition
    Via InvestorPlace
    Get Paid While You Wait: 7 Dividend Aristocrats to Buy Now
    Via InvestorPlace
    Medical Device Maker Becton Dickinson's Q1 Earnings: Here's Why This Analyst Is Bullish On Long-Term Prospects
    Via Benzinga
    Biotech And Medtech Portfolio Notes On A Fed Day
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
    Via Benzinga
    How Is The Market Feeling About Becton Dickinson?
    Via Benzinga
    Earnings Scheduled For February 1, 2024
    Via Benzinga
    Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
    Via Benzinga
    29 Undervalued Dividend Aristocrats: December 2023
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.